Cilengitide with cetuximab, cisplatin, and 5-FU in recurrent and/or metastatic squamous cell cancer of the head and neck: The ADVANTAGE phase II trial.Jan B. Vermorken, Paul M. Clément, Juergen Krauss et al.|Journal of Clinical Oncology|2012Cited by 7